Abstract
Despite advances in understanding the pathogenesis of asthma, a number of controversies regarding the optimal clinical management of asthma remain. This review of recent literature and current controversies, chosen mainly on the basis of relevance to clinical therapy, is directed toward nonspecialists caring for asthmatic patients.
MeSH terms
-
Adrenergic beta-Agonists / adverse effects
-
Adrenergic beta-Agonists / therapeutic use
-
Anti-Asthmatic Agents / therapeutic use*
-
Anti-Inflammatory Agents / therapeutic use
-
Asthma / drug therapy
-
Asthma / mortality
-
Asthma / therapy*
-
Emergency Medical Services
-
Humans
-
Immunotherapy
-
Status Asthmaticus / physiopathology
Substances
-
Adrenergic beta-Agonists
-
Anti-Asthmatic Agents
-
Anti-Inflammatory Agents